NO311497B1 - Anordning for administrering av pulverinhalasjonsmedikament - Google Patents

Anordning for administrering av pulverinhalasjonsmedikament Download PDF

Info

Publication number: NO311497B1
Authority: NO; Norway
Prior art keywords: capsule; vortex chamber; cover; nozzle; air
Prior art date: 1993-02-27

Application number

NO19953327A

Other languages

English (en)

Norwegian (no)

Other versions

NO953327L (no

NO953327D0 (no

Inventor

Brindra Paul Singh Chawla

Original Assignee

Fisons Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-27

Filing date

1995-08-24

Publication date

2001-12-03

1993-02-27 Priority claimed from GB939304011A external-priority patent/GB9304011D0/en

1993-06-05 Priority claimed from GB939311646A external-priority patent/GB9311646D0/en

1995-08-24 Application filed by Fisons Plc filed Critical Fisons Plc

1995-08-24 Publication of NO953327L publication Critical patent/NO953327L/no

1995-08-24 Publication of NO953327D0 publication Critical patent/NO953327D0/no

2001-12-03 Publication of NO311497B1 publication Critical patent/NO311497B1/no

Links

239000003814 drug Substances 0.000 title claims abstract description 54
229940079593 drug Drugs 0.000 title claims description 50
239000000843 powder Substances 0.000 title claims description 14
239000002775 capsule Substances 0.000 claims abstract description 67
238000004891 communication Methods 0.000 claims abstract description 12
238000000034 method Methods 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 3
230000000717 retained effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 description 6
239000004480 active ingredient Substances 0.000 description 5
239000002245 particle Substances 0.000 description 5
239000008188 pellet Substances 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
239000005557 antagonist Substances 0.000 description 3
239000000463 material Substances 0.000 description 3
JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 2
LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 2
229940124630 bronchodilator Drugs 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
229960001022 fenoterol Drugs 0.000 description 2
239000012634 fragment Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229960001317 isoprenaline Drugs 0.000 description 2
239000008101 lactose Substances 0.000 description 2
-1 polyethylene Polymers 0.000 description 2
229960002720 reproterol Drugs 0.000 description 2
WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 2
229960002052 salbutamol Drugs 0.000 description 2
239000007787 solid Substances 0.000 description 2
229960000195 terbutaline Drugs 0.000 description 2
229960005486 vaccine Drugs 0.000 description 2
PDNHLCRMUIGNBV-UHFFFAOYSA-N 1-pyridin-2-ylethanamine Chemical compound CC(N)C1=CC=CC=N1 PDNHLCRMUIGNBV-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
229940122459 Glutamate antagonist Drugs 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
239000000867 Lipoxygenase Inhibitor Substances 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
HEUMNKZPHGRBKR-UHFFFAOYSA-N [Na].[Cr] Chemical compound [Na].[Cr] HEUMNKZPHGRBKR-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000000556 agonist Substances 0.000 description 1
229920013820 alkyl cellulose Polymers 0.000 description 1
239000003194 amino acid receptor blocking agent Substances 0.000 description 1
230000001387 anti-histamine Effects 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
229950000210 beclometasone dipropionate Drugs 0.000 description 1
239000003152 bradykinin antagonist Substances 0.000 description 1
239000000168 bronchodilator agent Substances 0.000 description 1
229960004436 budesonide Drugs 0.000 description 1
239000000969 carrier Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000000812 cholinergic antagonist Substances 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
229960002881 clemastine Drugs 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229930182912 cyclosporin Natural products 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
230000003670 easy-to-clean Effects 0.000 description 1
229960002714 fluticasone Drugs 0.000 description 1
MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
229940047135 glycate Drugs 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
229960001361 ipratropium bromide Drugs 0.000 description 1
KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 1
239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
239000003120 macrolide antibiotic agent Substances 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000002483 medication Methods 0.000 description 1
229960004398 nedocromil Drugs 0.000 description 1
RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical class CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
229960002259 nedocromil sodium Drugs 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000000414 obstructive effect Effects 0.000 description 1
XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
229960004448 pentamidine Drugs 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229960001539 poliomyelitis vaccine Drugs 0.000 description 1
229920001281 polyalkylene Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
230000000246 remedial effect Effects 0.000 description 1
208000023504 respiratory system disease Diseases 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229960004017 salmeterol Drugs 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
239000012780 transparent material Substances 0.000 description 1
239000013598 vector Substances 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0031—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Manipulator (AREA)
Weting (AREA)
Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Catching Or Destruction (AREA)

NO19953327A 1993-02-27 1995-08-24 Anordning for administrering av pulverinhalasjonsmedikament NO311497B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB939304011A GB9304011D0 (en)	1993-02-27	1993-02-27	Inhalation device
GB939311646A GB9311646D0 (en)	1993-06-05	1993-06-05	Inhalation device
PCT/GB1994/000388 WO1994019041A1 (en)	1993-02-27	1994-02-28	Inhalation device

Publications (3)

Publication Number	Publication Date
NO953327L NO953327L (no)	1995-08-24
NO953327D0 NO953327D0 (no)	1995-08-24
NO311497B1 true NO311497B1 (no)	2001-12-03

Family

ID=26302515

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19953327A NO311497B1 (no)	1993-02-27	1995-08-24	Anordning for administrering av pulverinhalasjonsmedikament

Country Status (19)

Country	Link
US (1)	US5787881A (da)
EP (1)	EP0773807B1 (da)
JP (1)	JPH08507704A (da)
KR (1)	KR100297344B1 (da)
AT (1)	ATE185977T1 (da)
AU (1)	AU680874B2 (da)
BR (1)	BR9406253A (da)
CA (1)	CA2157043A1 (da)
DE (1)	DE69421415T2 (da)
DK (1)	DK0773807T3 (da)
ES (1)	ES2139733T3 (da)
FI (1)	FI953983A0 (da)
GR (1)	GR3031814T3 (da)
HU (1)	HU217896B (da)
IL (1)	IL108780A (da)
NO (1)	NO311497B1 (da)
NZ (1)	NZ261892A (da)
PL (1)	PL173041B1 (da)
WO (1)	WO1994019041A1 (da)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9302550D0 (sv) *	1993-07-30	1993-07-30	Ernst Hoerlin	Powder inhaler
JP3317823B2 (ja) *	1995-08-11	2002-08-26	株式会社ユニシアジェックス	投薬器
JP3328132B2 (ja) *	1996-03-21	2002-09-24	株式会社ユニシアジェックス	吸入式投薬器
GB9626233D0 (en) *	1996-12-18	1997-02-05	Chawla Brinda P S	Medicament packaging and deliveery device
US6062213A (en) *	1998-06-16	2000-05-16	Fuisz Technologies Ltd.	Single unit dose inhalation therapy device
GB2353222B (en) *	1999-06-23	2001-09-19	Cambridge Consultants	Inhalers
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
US7464706B2 (en)	1999-07-23	2008-12-16	Mannkind Corporation	Unit dose cartridge and dry powder inhaler
US7305986B1 (en)	1999-07-23	2007-12-11	Mannkind Corporation	Unit dose capsules for use in a dry powder inhaler
WO2002013897A2 (en)	2000-08-14	2002-02-21	Advanced Inhalation Research, Inc.	Inhalation device and method
US6357490B1 (en)	2000-08-22	2002-03-19	Advanced Inhalation Research, Inc.	System, method and apparatus for filling containers
SE0100034D0 (sv) *	2001-01-04	2001-01-04	Astrazeneca Ab	A delivery device
US6722364B2 (en) *	2001-01-12	2004-04-20	Becton, Dickinson And Company	Medicament inhalation delivery devices and methods for using the same
US6443152B1 (en) *	2001-01-12	2002-09-03	Becton Dickinson And Company	Medicament respiratory delivery device
DE60101451T2 (de) *	2001-03-05	2004-10-21	Pera Ivo E	Inhaliergerät zur Verteilung von in einer Kapsel enthaltenen Medikamenten in Pulverform durch die Atemwege
US6766799B2 (en) *	2001-04-16	2004-07-27	Advanced Inhalation Research, Inc.	Inhalation device
EP1392383A2 (en) *	2001-05-10	2004-03-03	Vectura Delivery Devices Limited	Inhalers
GB2375308A (en) *	2001-05-10	2002-11-13	Cambridge Consultants	Inhalers
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
GB0130055D0 (en)	2001-12-14	2002-02-06	Technology Innovation Ltd	Medicament packaging
SI1494732T1 (sl)	2002-03-20	2008-08-31	Mannking Corp	Inhalacijski aparat
DE602004028585D1 (de) *	2003-03-15	2010-09-23	Brin Tech Internat Ltd	Verpackung für Arzneimittel
GB0317374D0 (en)	2003-07-24	2003-08-27	Glaxo Group Ltd	Medicament dispenser
GB0410712D0 (en)	2004-05-13	2004-06-16	Novartis Ag	Organic compounds
GB0418278D0 (en) *	2004-08-16	2004-09-15	Glaxo Group Ltd	Medicament dispenser
JP5078014B2 (ja)	2004-08-20	2012-11-21	マンカインドコーポレイション	ジケトピペラジン合成の触媒反応
HUE025151T2 (en)	2004-08-23	2016-01-28	Mannkind Corp	Diceto-piperazine salts for drug delivery
US7694676B2 (en) *	2005-04-22	2010-04-13	Boehringer Ingelheim Gmbh	Dry powder inhaler
GB0515584D0 (en) *	2005-07-28	2005-09-07	Glaxo Group Ltd	Medicament dispenser
EP1928423B1 (en)	2005-09-14	2015-12-09	Mannkind Corporation	Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
AU2007210177C1 (en) *	2006-01-31	2012-11-01	Oriel Therapeutics, Inc.	Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP1986679B1 (en)	2006-02-22	2017-10-25	MannKind Corporation	A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
DE102006010089A1 (de) *	2006-02-24	2007-10-18	Aha-Kunststofftechnik Gmbh	Trockenpulver-Inhalator
GB0611656D0 (en) *	2006-06-13	2006-07-19	Cambridge Consultants	Dry powder inhalers
GB0616299D0 (en) *	2006-08-16	2006-09-27	Cambridge Consultants	Drug Capsules for dry power inhalers
GB0622827D0 (en) *	2006-11-15	2006-12-27	Glaxo Group Ltd	Sheet driver for use in a drug dispenser
WO2008091355A2 (en) *	2007-01-24	2008-07-31	Breathe Pharmaceuticals, Inc.	Drug transfer device
WO2008156586A2 (en) *	2007-06-12	2008-12-24	Alkermes, Inc.	Inhalation device for powdered substances
EP2534958A1 (en)	2007-12-14	2012-12-19	AeroDesigns, Inc	Delivering aerosolizable food products
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
KR101558026B1 (ko)	2008-06-13	2015-10-06	맨카인드 코포레이션	건조 분말 흡입기 및 약물 투여 시스템
CA2728523C (en)	2008-06-20	2020-03-10	Mannkind Corporation	An interactive apparatus and method for real-time profiling of inhalation efforts
WO2010011329A2 (en) *	2008-07-23	2010-01-28	Map Pharmaceuticals, Inc.	The delivery of powdered drug via inhalation
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
CA2738624A1 (en) *	2008-10-08	2010-04-15	Astrazeneca Ab	New device 503
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en)	2009-03-11	2013-09-17	Mannkind Corporation	Apparatus, system and method for measuring resistance of an inhaler
EP2440184B1 (en)	2009-06-12	2023-04-05	MannKind Corporation	Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
CA2779488A1 (en)	2009-11-12	2011-05-19	Stc.Unm	Dry powder inhaler with flutter dispersion member
CA2801936C (en)	2010-06-21	2021-06-01	Mannkind Corporation	Dry powder drug delivery system and methods
FR2962342B1 (fr) *	2010-07-07	2013-02-15	Valois Sas	Inhalateur de poudre seche.
FR2962341B1 (fr) *	2010-07-07	2013-02-15	Valois Sas	Inhalateur de poudre seche.
WO2012078804A1 (en)	2010-12-07	2012-06-14	Respira Therapeutics, Inc.	Dry powder inhaler
KR101940832B1 (ko)	2011-04-01	2019-01-21	맨카인드 코포레이션	의약 카트리지용 블리스터 패키지
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
DK2731573T3 (da) *	2011-07-13	2020-01-02	Pharmaxis Ltd	Forbedringer af indgivelsesanordninger
ES2770764T3 (es)	2011-07-13	2020-07-03	Pharmaxis Ltd	Mejoras relacionadas con dispositivos de suministro
CA2841402C (en) *	2011-07-13	2021-10-26	Pharmaxis Ltd	Improvements relating to delivery devices
BR112014004921B1 (pt)	2011-09-07	2020-12-08	Concentrx Pharmaceuticals, Inc.	dispositivo de inalação de pó seco
EP2776053A1 (en)	2011-10-24	2014-09-17	MannKind Corporation	Methods and compositions for treating pain
US10463815B2 (en)	2012-02-21	2019-11-05	Respira Therapeutics, Inc.	Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
CA2878457C (en)	2012-07-12	2021-01-19	Mannkind Corporation	Dry powder drug delivery systems and methods
US9764103B2 (en) *	2012-10-05	2017-09-19	Lily A. Neff	Salt puffer
EP2911690A1 (en)	2012-10-26	2015-09-02	MannKind Corporation	Inhalable influenza vaccine compositions and methods
WO2014144895A1 (en)	2013-03-15	2014-09-18	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
BR122019026637B1 (pt)	2013-07-18	2023-09-26	Mannkind Corporation	Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
WO2015021064A1 (en)	2013-08-05	2015-02-12	Mannkind Corporation	Insufflation apparatus and methods
WO2015148905A1 (en)	2014-03-28	2015-10-01	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
MY182482A (en) *	2014-11-10	2021-01-25	Japan Tobacco Inc	Cartridge and non-burning type flavor inhaler
WO2016115379A1 (en)	2015-01-14	2016-07-21	Respira Therapeutics, Inc.	Powder dispersion methods and devices
PT108426B (pt) *	2015-04-30	2017-07-24	Hovione Farmaciência S A	Inalador de pó para administração de doses elevadas de fármacos
ES2760943T3 (es) *	2016-05-23	2020-05-18	Presspart Mfg Ltd	Inhalador de polvo seco
EP3600504B1 (en)	2017-03-28	2023-07-12	Concentrx Pharmaceuticals, Inc.	Device for delivering dry powder medicaments
KR101992171B1 (ko) *	2017-06-27	2019-06-25	한국유나이티드제약 주식회사	건조분말 흡입기
CN110201281B (zh) *	2018-02-28	2021-08-06	张江	吸入给药装置和吸入给药组合结构
CA193818S (en) *	2020-03-11	2022-04-20	Breathesuite Inc	Monitoring device for inhalers
KR102662529B1 (ko) *	2021-09-02	2024-04-30	중앙대학교 산학협력단	휴대용 약물 흡입기

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4069819A (en) *	1973-04-13	1978-01-24	Societa Farmaceutici S.P.A.	Inhalation device
IT1016489B (it) *	1974-03-18	1977-05-30	Isf Spa	Inalatore
AT384552B (de) *	1985-08-01	1987-12-10	Hurka Wilhelm	Inhalationsgeraet zur dosierung und verteilung von festkoerpern in die atemluft
GB8804069D0 (en) *	1988-02-22	1988-03-23	Britains Petite Ltd	Dispensers for powdered medication
IT1228460B (it) *	1989-02-23	1991-06-19	Phidea S R L	Inalatore monouso con capsula pre-forata
IT1237118B (it) *	1989-10-27	1993-05-18	Miat Spa	Inalatore multidose per farmaci in polvere.
IL111254A (en) *	1990-06-14	1998-10-30	Rhone Poulenc Rorer Ltd	Powder inhalers
US5429122A (en) *	1990-09-26	1995-07-04	Zanen; Pieter	Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber
EP0504459B1 (de) *	1991-03-21	1996-06-05	PAUL RITZAU PARI-WERK GmbH	Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie
GB9106648D0 (en) *	1991-03-28	1991-05-15	Rhone Poulenc Rorer Ltd	New inhaler
US5476093A (en) *	1992-02-14	1995-12-19	Huhtamaki Oy	Device for more effective pulverization of a powdered inhalation medicament
DK0659150T3 (da) *	1992-09-09	1997-09-29	Fisons Plc	Farmaceutisk emballage.
US5349947A (en) *	1993-07-15	1994-09-27	Newhouse Michael T	Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
DE59409856D1 (de) *	1994-05-19	2001-10-11	Pari Gmbh	Vorrichtung zur Trocknung und Pufferung von Aerosolen

1994
- 1994-02-27 IL IL10878094A patent/IL108780A/en not_active IP Right Cessation
- 1994-02-28 AT AT94907642T patent/ATE185977T1/de not_active IP Right Cessation
- 1994-02-28 EP EP94907642A patent/EP0773807B1/en not_active Expired - Lifetime
- 1994-02-28 ES ES94907642T patent/ES2139733T3/es not_active Expired - Lifetime
- 1994-02-28 AU AU61136/94A patent/AU680874B2/en not_active Ceased
- 1994-02-28 DK DK94907642T patent/DK0773807T3/da active
- 1994-02-28 DE DE69421415T patent/DE69421415T2/de not_active Expired - Fee Related
- 1994-02-28 WO PCT/GB1994/000388 patent/WO1994019041A1/en active IP Right Grant
- 1994-02-28 HU HU9502496A patent/HU217896B/hu not_active IP Right Cessation
- 1994-02-28 JP JP6518782A patent/JPH08507704A/ja not_active Ceased
- 1994-02-28 KR KR1019950703654A patent/KR100297344B1/ko not_active IP Right Cessation
- 1994-02-28 CA CA002157043A patent/CA2157043A1/en not_active Abandoned
- 1994-02-28 NZ NZ261892A patent/NZ261892A/en unknown
- 1994-02-28 PL PL94310433A patent/PL173041B1/pl unknown
- 1994-02-28 BR BR9406253A patent/BR9406253A/pt not_active IP Right Cessation
1995
- 1995-08-24 NO NO19953327A patent/NO311497B1/no not_active IP Right Cessation
- 1995-08-24 FI FI953983A patent/FI953983A0/fi unknown
1997
- 1997-02-03 US US08/789,073 patent/US5787881A/en not_active Expired - Fee Related
1999
- 1999-11-10 GR GR990402907T patent/GR3031814T3/el unknown

Also Published As

Publication number	Publication date
BR9406253A (pt)	1996-02-13
HUT73520A (en)	1996-08-28
AU6113694A (en)	1994-09-14
HU217896B (hu)	2000-05-28
WO1994019041A1 (en)	1994-09-01
JPH08507704A (ja)	1996-08-20
FI953983A (fi)	1995-08-24
HU9502496D0 (en)	1995-10-30
FI953983A0 (fi)	1995-08-24
DE69421415T2 (de)	2000-02-10
ES2139733T3 (es)	2000-02-16
AU680874B2 (en)	1997-08-14
EP0773807B1 (en)	1999-10-27
IL108780A (en)	1999-06-20
GR3031814T3 (en)	2000-02-29
IL108780A0 (en)	1994-05-30
CA2157043A1 (en)	1994-09-01
PL310433A1 (en)	1995-12-11
ATE185977T1 (de)	1999-11-15
DE69421415D1 (de)	1999-12-02
DK0773807T3 (da)	2000-04-17
US5787881A (en)	1998-08-04
EP0773807A1 (en)	1997-05-21
KR100297344B1 (ko)	2001-10-24
NZ261892A (en)	1997-07-27
NO953327L (no)	1995-08-24
NO953327D0 (no)	1995-08-24
PL173041B1 (pl)	1998-01-30

Legal Events

Date	Code	Title	Description
2004-12-20	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO311497B1 (no)	2001-12-03	Anordning for administrering av pulverinhalasjonsmedikament
JP5651233B2 (ja)	2015-01-07	簡易なカプセル・ベースの吸入器
RU2393883C1 (ru)	2010-07-10	Простой ингалятор
JP4497730B2 (ja)	2010-07-07	複合薬剤用の粉末吸入器
JP4975251B2 (ja)	2012-07-11	単位用量乾燥粉末吸入器
FI67026B (fi)	1984-09-28	Andningsaktiverad anordning foer oral inhalation av pulverformiga laekemedel
AU2010249402B2 (en)	2014-08-21	Rotary cassette system for dry powder inhaler
US7025058B2 (en)	2006-04-11	Metered dose delivery device for liquid and powder agents
KR0159044B1 (ko)	1998-11-16	산제의약품 투여용 흡입기
JPH0147190B2 (da)	1989-10-12
KR20100103813A (ko)	2010-09-28	에어로졸화가능 제약 제제의 저장기
SI9500036A (en)	1995-08-31	New inhalator device
ES2728076T3 (es)	2019-10-22	Medicamentos inhalables
WO2009091780A2 (en)	2009-07-23	Device for inhaling powdered medicaments